Pharmacokinetics and pharmacodynamic effect of a blood-brain barrier-crossing fusion protein therapeutic for Alzheimer’s disease in rat and dog

From National Research Council Canada

Download
  1. (PDF, 1.2 MiB)
DOIResolve DOI: https://doi.org/10.1007/s11095-022-03285-z
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1; Search for: 1
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
SubjectAlzheimer's disease; blood-brain barrier-crossing biologics; CNS exposure; pharmacodynamics; pharmacokinetics
Abstract
Publication date
PublisherSpringer Nature
Licence
In
LanguageEnglish
Peer reviewedYes
Identifier3285
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifierf46400b2-446c-49ba-a6c4-94eb4f15a6c2
Record created2024-02-27
Record modified2024-02-27
Date modified: